Octagon Capital Advisors LP Allovir, Inc. Transaction History
Octagon Capital Advisors LP
- $639 Million
- Q1 2024
A detailed history of Octagon Capital Advisors LP transactions in Allovir, Inc. stock. As of the latest transaction made, Octagon Capital Advisors LP holds 4,200,000 shares of ALVR stock, worth $3.23 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
4,200,000Holding current value
$3.23 Million% of portfolio
0.5%Shares
1 transactions
Others Institutions Holding ALVR
# of Institutions
81Shares Held
49.1MCall Options Held
385KPut Options Held
2.3K-
Eco R1 Capital, LLC San Francisco, CA11.3MShares$8.7 Million0.24% of portfolio
-
Artal Group S.A. Luxembourg, N46.6MShares$5.08 Million0.27% of portfolio
-
Black Rock Inc. New York, NY3.39MShares$2.61 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.94MShares$2.27 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$2.25 Million0.0% of portfolio
About Allovir, Inc.
- Ticker ALVR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,063,400
- Market Cap $71.7M
- Description
- Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...